Literature DB >> 26994009

Abnormalities of the bone marrow immune microenvironment in patients with immune thrombocytopenia.

Yang Song1,2, Yu-Tong Wang1, Xiao-Jun Huang1,2, Yuan Kong3.   

Abstract

Immune thrombocytopenia (ITP) is an acquired autoimmune disease. Although antiplatelet antibodies are considered as the primary immunologic defect in these patients, dysfunctional cellular immunity is also important in the pathophysiology of ITP. Peripheral T cell abnormalities have been demonstrated in patients with ITP; however, whether the impaired bone marrow (BM) microenvironment, specifically the BM immune microenvironment, is involved in the pathogenesis of ITP remains unknown. In this study, the compartments of the BM immune microenvironment and BM vascular microenvironment were analyzed in 26 untreated patients with ITP and 26 healthy donors (HD). Subsets of T cells in the BM immune microenvironment, including Th1, Th2, Tc1, Tc2, Th17, and Treg cells, were analyzed via flow cytometry. BM endothelial cells and perivascular cells, which are key elements of the vascular microenvironment, were analyzed via flow cytometry as well as hematoxylin-eosin (H&E) and immunohistochemical (IHC) staining in situ. Elements of the BM vascular microenvironment were found to be normal in patients with ITP, but abnormal characteristics of the BM immune microenvironment, including excessive polarization in Th1, Tc1, and Th17 cells and a remarkable decrease in Treg cells, were observed in patients with ITP. Therefore, a deregulated T cell response in the BM microenvironment might play an important role in the pathogenesis of ITP.

Entities:  

Keywords:  Bone marrow; ITP; Immune; Microenvironment

Mesh:

Substances:

Year:  2016        PMID: 26994009     DOI: 10.1007/s00277-016-2641-y

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  11 in total

1.  Dysregulated megakaryocyte distribution associated with nestin+ mesenchymal stem cells in immune thrombocytopenia.

Authors:  Min Wang; Ru Feng; Jia-Min Zhang; Lin-Lin Xu; Fei-Er Feng; Chen-Cong Wang; Qian-Ming Wang; Xiao-Lu Zhu; Yun He; Jing Xue; Hai-Xia Fu; Meng Lv; Yuan Kong; Ying-Jun Chang; Lan-Ping Xu; Kai-Yan Liu; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Blood Adv       Date:  2019-05-14

2.  Improved function and balance in T cell modulation by endothelial cells in young people.

Authors:  Shu-Qian Tang; Wei-Li Yao; Ya-Zhe Wang; Yuan-Yuan Zhang; Hong-Yan Zhao; Qi Wen; Yu Wang; Lan-Ping Xu; Xiao-Hui Zhang; Xiao-Jun Huang; Yuan Kong
Journal:  Clin Exp Immunol       Date:  2021-08-22       Impact factor: 4.330

3.  Aberrant T cell responses in the bone marrow microenvironment of patients with poor graft function after allogeneic hematopoietic stem cell transplantation.

Authors:  Yuan Kong; Yu-Tong Wang; Xie-Na Cao; Yang Song; Yu-Hong Chen; Yu-Qian Sun; Yu Wang; Xiao-Hui Zhang; Lan-Ping Xu; Xiao-Jun Huang
Journal:  J Transl Med       Date:  2017-03-14       Impact factor: 5.531

4.  Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy.

Authors:  Eileen Shiuan; Kathryn E Beckermann; Alpaslan Ozgun; Ciara Kelly; Meredith McKean; Jennifer McQuade; Mary Ann Thompson; Igor Puzanov; John P Greer; Suthee Rapisuwon; Michael Postow; Michael A Davies; Zeynep Eroglu; Douglas Johnson
Journal:  J Immunother Cancer       Date:  2017-02-21       Impact factor: 13.751

5.  All-trans retinoic acid protects mesenchymal stem cells from immune thrombocytopenia by regulating the complement-interleukin-1β loop.

Authors:  Xiaolu Zhu; Yanan Wang; Qian Jiang; Hao Jiang; Jin Lu; Yazhe Wang; Yuan Kong; Yingjun Chang; Lanping Xu; Jun Peng; Ming Hou; Xiaojun Huang; Xiaohui Zhang
Journal:  Haematologica       Date:  2019-01-24       Impact factor: 9.941

6.  Increased levels of the megakaryocyte and platelet expressed cysteine proteases stefin A and cystatin A prevent thrombosis.

Authors:  Anna Mezzapesa; Delphine Bastelica; Lydie Crescence; Marjorie Poggi; Michel Grino; Franck Peiretti; Laurence Panicot-Dubois; Annabelle Dupont; René Valero; Marie Maraninchi; Jean-Claude Bordet; Marie-Christine Alessi; Christophe Dubois; Matthias Canault
Journal:  Sci Rep       Date:  2019-07-03       Impact factor: 4.379

7.  Disrupted balance of CD4+ T-cell subsets in bone marrow of patients with primary immune thrombocytopenia.

Authors:  Qian Wang; Juan Li; Tian-Shu Yu; Yu Liu; Kai Li; Shuang Liu; Yang Liu; Qi Feng; Lei Zhang; Guo-Sheng Li; Lin-Lin Shao; Jun Peng; Ming Hou; Xin-Guang Liu
Journal:  Int J Biol Sci       Date:  2019-10-23       Impact factor: 6.580

8.  Clinical efficacy of high-dose dexamethasone with sequential prednisone maintenance therapy for newly diagnosed adult immune thrombocytopenia in a real-world setting.

Authors:  Jin Xu; Xinhui Zhang; Shanglong Feng; Na Zhao; Xin Hu; Yaxin Cheng; Yue Wu; Li Zhou; Juan Tong; Changcheng Zheng
Journal:  J Int Med Res       Date:  2021-04       Impact factor: 1.671

9.  Abnormalities of bone marrow B cells and plasma cells in primary immune thrombocytopenia.

Authors:  Tian-Shu Yu; Hao-Yi Wang; Ya-Jing Zhao; Ya-Fei Yu; Yu Hou; Shuang Liu; Pan-Pan Han; Xiao-Fei Ni; Xue-Bin Ji; Jun Peng; Xin-Guang Liu; Ming Hou
Journal:  Blood Adv       Date:  2021-10-26

10.  Different subsets of haematopoietic cells and immune cells in bone marrow between young and older donors.

Authors:  W-L Yao; Q Wen; H-Y Zhao; S-Q Tang; Y-Y Zhang; Y Wang; L-P Xu; X-H Zhang; X-J Huang; Y Kong
Journal:  Clin Exp Immunol       Date:  2020-10-21       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.